We are live on
!
Find out more
KCM
KRS Capital Management Portfolio holdings
AUM
$215M
1-Year Est. Return
69.3%
This Fund
S&P 500
This Quarter
Est. Return
-3.53%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.8M
AUM Growth
-$6.23M
(-6.2%)
Cap. Flow
-$257K
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
43.99%
Holding
117
New
5
Increased
47
Reduced
35
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$1.45M |
| 2 |
Cadence Design Systems
CDNS
|
+$366K |
| 3 |
Oracle
ORCL
|
+$347K |
| 4 |
Carrier Global
CARR
|
+$290K |
| 5 |
Parker-Hannifin
PH
|
+$246K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$2.85M |
| 2 |
Walt Disney
DIS
|
+$242K |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$228K |
| 4 |
PayPal
PYPL
|
+$227K |
| 5 |
Dollar General
DG
|
+$217K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 51.13% |
| 2 | Healthcare | 14.49% |
| 3 | Consumer Discretionary | 7.64% |
| 4 | Financials | 7.3% |
| 5 | Industrials | 5.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
iShares S&P 500 Value ETF
IVE
$49.6B
| $230K | 0.25% |
1,495
| – | – |
|
102
Ford
F
$55B
| $228K | 0.24% |
18,322
-427
| -2% | -$5.54K |
|
103
Vanguard S&P 500 ETF
VOO
$1.01T
| $226K | 0.24% |
576
| – | – |
|
104
Marathon Petroleum
MPC
$84B
| $224K | 0.24% |
+1,482
| New | +$207K |
|
105
DexCom
DXCM
$31.3B
| $224K | 0.24% |
2,400
| – | – |
|
106
Automatic Data Processing
ADP
$109B
| $223K | 0.24% |
925
| – | – |
|
107
Pfizer
PFE
$149B
| $221K | 0.24% |
6,671
-1,380
| -17% | -$48.8K |
|
|
108
Bank of America
BAC
$441B
| $215K | 0.23% |
56,021
+48,904
| +687% | +$1.45M |
|
|
109
Walt Disney
DIS
$181B
| $213K | 0.23% |
2,631
-2,835
| -52% | -$242K |
|
110
CVS Health
CVS
$123B
| $210K | 0.22% |
3,004
-2,326
| -44% | -$165K |
|
111
Carlyle Group
CG
$17.6B
| $210K | 0.22% |
+6,950
| New | +$224K |
|
|
112
Dollar General
DG
$28.1B
| – | – |
-1,280
| Closed | -$217K |
|
113
Devon Energy
DVN
$47.4B
| – | – |
-4,491
| Closed | -$217K |
|
114
SoFi Technologies
SOFI
$23.4B
| – | – |
-12,045
| Closed | -$100K |
|
115
United Parcel Service
UPS
$87.8B
| – | – |
-1,174
| Closed | -$210K |
|
|
116
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| – | – |
-2,745
| Closed | -$228K |
|
|
RETA
117
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| – | – |
-27,941
| Closed | -$2.85M |
|
Similar funds
VFG
IAM
VEA
RC
NCM
TSS
CMBA
IH
KRS Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, KRS Capital Management held 117 positions worth $93.8M, down 6.2% from $100M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
KRS Capital Management's Q3 2023 filing shows 5 new, 47 increased, 35 reduced and 6 closed positions. Its largest new stake was Cadence Design Systems: 1,562 shares worth $366K. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $2.85M.
By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 50% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- KRS Capital Management's largest Q3 2023 buy was Cadence Design Systems: 1,562 shares worth $366K.
- KRS Capital Management added most to Bank of America in Q3 2023, an estimated $1.45M increase.
- KRS Capital Management's biggest Q3 2023 reduction was Walt Disney, cutting an estimated $242K.
- KRS Capital Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $2.85M.
- KRS Capital Management's ten largest holdings make up 44% of its $93.8M portfolio in Q3 2023.
- KRS Capital Management opened 5 new positions and closed 6 in Q3 2023.
- KRS Capital Management's portfolio value fell 6.2% quarter-over-quarter to $93.8M.
Based on KRS Capital Management's 13F filing for Q3 2023, filed 19 Oct 2023.